MBRX Moleculin Biotech Inc
Company Analysis
Latest News
Moleculin Shares Drop Over 16% After 1-for-20 Reverse Split Announcement
Moleculin Biotech announced a 1-for-20 reverse stock split of its common stock, effective at 12:01 a.m. ET on October 20, 2026. The stock is expected to begin...
🔴 Moleculin Biotech is trading 12.32% down with no clear catalyst identified
Moleculin Biotech is trading 12.32% down at $0.32, with no clear company-specific catalyst identified for October 16, 2026. - The latest listed company...
🔴 Moleculin Biotech is trading 18.27% down in pre-market — no clear company-specific catalyst identified
Moleculin Biotech is trading at $0.30, down 18.27% in pre-market, with no clear company-specific catalyst identified. - Its latest listed release is an...
🟢 Moleculin Biotech is trading 5.9% up in pre-market — no clear catalyst identified
Moleculin Biotech is trading at $0.39, up 5.94%, in pre-market, with no clear company-specific catalyst identified. - The company’s press-release page lists...
🟢 Moleculin Biotech is trading 5.4% up in after-hours trading with no clear company-specific catalyst
Moleculin Biotech is trading 5.38% up at $0.39 in after-hours, with no clear company-specific catalyst identified. - Its regular-session close was $0.37 on...
🔴 Moleculin Biotech is trading 5.8% down
Moleculin Biotech is trading 5.8% lower at $0.39, with the cause of the October 15 decline still uncertain. - Available search results showed no new...
🔴 Moleculin Biotech is trading 5.5% down alongside a 2.01% decline in biotech ETF XBI
Moleculin Biotech is trading at $0.41 (-5.51%), in line with biotech-sector weakness and broader equity declines. - Biotech ETF XBI was down 2.01% in the...
🟢 Moleculin Biotech is trading 14.8% up in pre-market ahead of October 14 Maxim Growth Summit presentation
Moleculin Biotech is trading at $0.50, up 14.75% in pre-market ahead of its scheduled presentation; available sources do not establish a causal link. - The...
🔴 Moleculin Biotech is trading 5% down today with no identified company-specific explanation
Moleculin Biotech is trading 5.07% lower at $0.42, with no company announcement identified that specifically explains the October 12 decline. - The company’s...
MBRX Shareholders Approve Potential Reverse Stock Split and Increased Equity Plan Shares
Moleculin Biotech, Inc. announced the results of its 2026 Annual Meeting of Stockholders, where shareholders approved two key proposals: granting the Board of...
🟢 Moleculin Biotech rises 5.3% — Biotech Sector Rallies on Strong IPO Debuts and M&A Activity
With Biotech (XBI) up 2.5%, this looks like a sector-led move rather than a company-specific surprise. The biotech sector is experiencing a significant rally,...
🔴 Moleculin Biotech is trading 5.4% down with no confirmed company-specific catalyst
Moleculin Biotech is trading at $0.42 (-5.42%) amid biotech-sector weakness, though a direct cause is unconfirmed. - The latest company announcement found was...
🟢 Moleculin Biotech is trading 5% up in pre-market
Moleculin Biotech is trading at $0.47, up 5.25% in pre-market on October 7, 2026; available coverage identifies no company-specific catalyst. - Shares closed...
🟢 Moleculin Biotech is trading 5.5% up in after-hours trading with no identified catalyst
Moleculin Biotech is trading 5.5% higher in after-hours trading at $0.47, versus the regular-session close of $0.45; no catalyst was identified. - The regular...
🔴 Moleculin Biotech is trading 5.5% down today amid biotech-sector weakness
Moleculin Biotech is trading at $0.45, down 5.52%, with biotech-sector weakness a possible contributing factor. - No clear company-specific catalyst was...
🔴 Moleculin Biotech is trading 5% down; no clear company-specific catalyst identified
Moleculin Biotech is trading at $0.46, down 5.14%, with no clear company-specific catalyst identified for the October 5 decline. - The latest reported company...
🔴 Moleculin Biotech is trading 5% down as no clear company-specific cause was identified
Moleculin Biotech is trading 5% lower at $0.48, with no clear company-specific explanation identified for the October 2 move. - Its latest listed releases were...
🔴 Moleculin Biotech is trading 5% down with no company-specific catalyst identified
Moleculin Biotech is trading 5.02% down at $0.50 on September 30, 2026, with no company-specific announcement found to explain the decline. - The latest major...
MBRX Completes Enrollment in Pivotal AML Trial, Data Readout Expected Q1 2027
Moleculin Biotech, Inc. announced it has completed and closed patient enrollment for Part A of its pivotal Phase 2/3 MIRACLE trial. The study is evaluating its...
🔴 Moleculin Biotech is trading 5.9% down
Moleculin Biotech is trading 5.9% lower at $0.54; the provided information does not establish a catalyst for the decline. - Shares closed down 5.42% at $0.57...